Related references
Note: Only part of the references are listed.Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease
Muhammad Aslam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Bone marrow stromal cells attenuate sepsis via prostaglandin E-2-dependent reprogramming of host macrophages to increase their interleukin-10 production
Krisztian Nemeth et al.
NATURE MEDICINE (2009)
Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung
Jae W. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
Massimiliano Gnecchi et al.
CIRCULATION RESEARCH (2008)
Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality?
Patricia R. M. Rocco et al.
CURRENT OPINION IN CRITICAL CARE (2008)
Harmful molecular mechanisms in sepsis
Daniel Rittirsch et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice
Jianguo Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1
Shirley H. J. Mei et al.
PLOS MEDICINE (2007)
Drug therapy: Management of sepsis
Jarnes A. Russell
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality
Marcin F. Osuchowski et al.
JOURNAL OF IMMUNOLOGY (2006)
Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves
Puspa Batten et al.
TISSUE ENGINEERING (2006)
Regenerative and immunomodulatory potential of mesenchymal stem cells
Mauro Krampera et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells
Mauro Krampera et al.
STEM CELLS (2006)
Clarification of the nomenclature for MSC: The international society for cellular therapy position statement
EM Horwitz et al.
CYTOTHERAPY (2005)
Animal models of sepsis: Setting the stage
JA Buras et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
E Zappia et al.
BLOOD (2005)
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness
S Beyth et al.
BLOOD (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Mesenchymal stem cells: clinical applications and biological characterization
FP Barry et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential
A Peister et al.
BLOOD (2004)
Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy
D Baksh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2004)
Therapeutic approaches to innate immunity: Severe sepsis and septic shock
E Lolis et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice
T Miyaji et al.
KIDNEY INTERNATIONAL (2003)
Immunomodulatory effects of fetal and adult mesenchymal stem cells
K Le Blanc
CYTOTHERAPY (2003)
Stem cell plasticity: The growing potential of cellular therapy
EM Horwitz
ARCHIVES OF MEDICAL RESEARCH (2003)
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
ON Koç et al.
BONE MARROW TRANSPLANTATION (2002)
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
EM Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
Animal and human models for sepsis
MJ Schultz et al.
ANNALS OF MEDICINE (2002)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mesenchymal stem cells:: heading into the clinic
ON Koç et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
